CCL2 and cancer: In summary, to achieve sufficient efficacy of CCL2–CCR2-targeted therapy for cancer patients, it is not sufficient to target cancer cells or immune cells alone and it is necessary to fully elucidate the physiological functions of the CCL2–CCR2 axis against a variety of normal cells expressing CCR2.